The Perth-based company said the response of Australian payers to the home-grown innovation stands in stark contrast to the "traction" gained in the US and UK.
Frustration for Australian company looking to secure funding for home-grown innovation
March 17, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
Astellas bets up to US$1.34 billion on Melbourne startup's cancer candidate
October 28, 2026 - - Latest News -
The stakes are very high on access in a contested budget environment
October 28, 2026 - - Latest News -
Managing an agreement negotiation as a 'prisoner of circumstance'
October 28, 2026 - - Latest News -
MSAC suggests minister skip HTA and make policy fix to ensure access to this technology
October 28, 2026 - - Latest News -
AusBiotech takes 15-year refund limit fight to the Senate as R&D tax bill lands
October 28, 2026 - - Latest News -
Lung scarring killing 11 Australians a day, with one in five cases traced to work
October 28, 2026 - - Latest News -
Company rebates fall for the first time in years, lifting net PBS costs
October 27, 2026 - - Latest News
